Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharmaceutical company reports Q4 05 revenues of $437,000, down from $2.6 million in Q4 04
February 27th, 2006
XenoPort, Inc. (XNPT) announced in its financial results for the fourth quarter and year ended December 31, 2005 that revenues for the quarter were $437,000, compared to $2.6 million for the same period in 2004. Net loss for the fourth quarter was $11.5 million, compared to a net loss of $9.1 million for the same period in 2004. At December 31, 2005, XenoPort had cash and cash equivalents and short-term investments of $91.9 million. Revenues for the 12 months ended December 31, 2005 were $4.8 million, compared to $10 million for the same period in 2004. The decline in fourth quarter revenues was primarily due to the conclusion of our research...
Source: Pharma Business Week (2006-02-27)
|
